Am J Perinatol 2021; 38(09): 869-879
DOI: 10.1055/s-0040-1721715
SMFM Fellowship Series Article

Implementation and Evaluation of an Electronic Maternal Early Warning Trigger Tool to Reduce Maternal Morbidity

Elizabeth A. Blumenthal
1   Department of Obstetrics and Gynecology, University of California, Irvine, Orange, California
,
Nina Hooshvar
1   Department of Obstetrics and Gynecology, University of California, Irvine, Orange, California
,
Virginia Tancioco
1   Department of Obstetrics and Gynecology, University of California, Irvine, Orange, California
,
Rachel Newman
1   Department of Obstetrics and Gynecology, University of California, Irvine, Orange, California
,
1   Department of Obstetrics and Gynecology, University of California, Irvine, Orange, California
,
Jennifer McNulty
2   Department of Obstetrics and Gynecology, Long Beach Memorial Miller Children's and Women's Hospital, Long Beach, California
› Institutsangaben
Funding None.

Abstract

Objective We compare maternal morbidity and clinical care metrics before and after the electronic implementation of a maternal early warning trigger (MEWT) tool.

Study Design This is a study of maternal morbidity and clinical care within three linked hospitals comparing 1 year before and after electronic MEWT implementation. We compare severe maternal morbidity overall as well as within the subcategories of hemorrhage, hypertension, cardiopulmonary, and sepsis in addition to relevant process metrics in each category. We describe the MEWT trigger rate in addition to MEWT sensitivity and specificity for morbidity overall and by morbidity type.

Results The morbidity rate ratio increased from 1.6 per 100 deliveries in the pre-MEWT period to 2.06 per 100 deliveries in the post-MEWT period (incidence rate ratio = 1.28, p = 0.018); however, in cases of septic morbidity, time to appropriate antibiotics decreased (pre-MEWT: 1.87 hours [1.11–2.63] vs. post-MEWT: 0.75 hours [0.31–1.19], p = 0.036) and in cases of hypertensive morbidity, the proportion of cases treated with appropriate antihypertensive medication within 60 minutes improved (pre-MEWT: 62% vs. post-MEWT: 83%, p = 0.040). The MEWT trigger rate was 2.3%, ranging from 0.8% in the less acute centers to 2.9% in our tertiary center. The MEWT sensitivity for morbidity overall was 50%; detection of hemorrhage morbidity was lowest (30%); however, it ranged between 69% for septic morbidity, 74% for cardiopulmonary morbidity, and 82% for cases of hypertensive morbidity.

Conclusion Overall, maternal morbidity did not decrease after implementation of the MEWT system; however, important clinical metrics such as time to antibiotics and antihypertensive care improved. We suspect increased morbidity was related to annual variation and unexpected lower morbidity in the pre-MEWT comparison year. Because MEWT sensitivity for hemorrhage was low, and because hemorrhage dominates administrative metrics of morbidity, process metrics around sepsis, hypertension, and cardiopulmonary morbidity are important to track as markers of MEWT efficacy.

Key Points

  • MEWT was not associated with a decrease in maternal morbidity.

  • MEWT was associated with improvements in some clinical care metrics.

  • MEWT is more sensitive in detecting septic, hypertensive, and cardiopulmonary morbidities than hemorrhage morbidity.

Supplementary Material



Publikationsverlauf

Eingereicht: 19. Juni 2020

Angenommen: 04. November 2020

Artikel online veröffentlicht:
27. Dezember 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Main EK, Menard MK. Maternal mortality: time for national action. Obstet Gynecol 2013; 122 (04) 735-736
  • 2 Hirshberg A, Srinivas SK. Epidemiology of maternal morbidity and mortality. Semin Perinatol 2017; 41 (06) 332-337
  • 3 Centers for Disease Control and Prevention. Pregnancy mortality surveillance system. Accessed January 13, 2019 at: http://www.cdc.gov/reproductivehealth/maternalinfanthealth/pregnancy-mortality-surveillancesystem.html
  • 4 Alam N, Hobbelink EL, van Tienhoven AJ, van de Ven PM, Jansma EP, Nanayakkara PW. The impact of the use of the Early Warning Score (EWS) on patient outcomes: a systematic review. Resuscitation 2014; 85 (05) 587-594
  • 5 Friedman AM, Campbell ML, Kline CR, Wiesner S, D'Alton ME, Shields LE. Implementing obstetric early warning systems. AJP Rep 2018; 8 (02) e79-e84
  • 6 Callaghan WM, Grobman WA, Kilpatrick SJ, Main EK, DʼAlton M. Facility-based identification of women with severe maternal morbidity: it is time to start. Obstet Gynecol 2014; 123 (05) 978-981
  • 7 Grobman WA, Bailit JL, Rice MM. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Frequency of and factors associated with severe maternal morbidity. Obstet Gynecol 2014; 123 (04) 804-810
  • 8 Arora KS, Shields LE, Grobman WA, D'Alton ME, Lappen JR, Mercer BM. Triggers, bundles, protocols, and checklists--what every maternal care provider needs to know. Am J Obstet Gynecol 2016; 214 (04) 444-451
  • 9 Mhyre JM, D'Oria R, Hameed AB. et al. The maternal early warning criteria: a proposal from the national partnership for maternal safety. J Obstet Gynecol Neonatal Nurs 2014; 43 (06) 771-779
  • 10 Ludikhuize J, Smorenburg SM, de Rooij SE, de Jonge E. Identification of deteriorating patients on general wards; measurement of vital parameters and potential effectiveness of the Modified Early Warning Score. J Crit Care 2012; 27 (04) 424.e7-424.e13
  • 11 Moon A, Cosgrove JF, Lea D, Fairs A, Cressey DM. An eight year audit before and after the introduction of modified early warning score (MEWS) charts, of patients admitted to a tertiary referral intensive care unit after CPR. Resuscitation 2011; 82 (02) 150-154
  • 12 Trinkle RM, Flabouris A. Documenting rapid response system afferent limb failure and associated patient outcomes. Resuscitation 2011; 82 (07) 810-814
  • 13 Maupin JM, Roth DJ, Krapes JM. Use of the modified early warning score decreases code blue events. Jt Comm J Qual Patient Saf 2009; 35 (12) 598-603
  • 14 Zuckerwise LC, Lipkind HS. Maternal early warning systems-towards reducing preventable maternal mortality and severe maternal morbidity through improved clinical surveillance and responsiveness. Semin Perinatol 2017; 41 (03) 161-165
  • 15 McNeill G, Bryden D. Do either early warning systems or emergency response teams improve hospital patient survival? A systematic review. Resuscitation 2013; 84 (12) 1652-1667
  • 16 Bunkenborg G, Samuelson K, Poulsen I, Ladelund S, Åkeson J. Lower incidence of unexpected in-hospital death after interprofessional implementation of a bedside track-and-trigger system. Resuscitation 2014; 85 (03) 424-430
  • 17 Mathukia C, Fan W, Vadyak K, Biege C, Krishnamurthy M. Modified early warning system improves patient safety and clinical outcomes in an academic community hospital. J Community Hosp Intern Med Perspect 2015; 5 (02) 26716
  • 18 Singh S, McGlennan A, England A, Simons R. A validation study of the CEMACH recommended modified early obstetric warning system (MEOWS). Anaesthesia 2012; 67 (01) 12-18
  • 19 Hedriana HL, Wiesner S, Downs BG, Pelletreau B, Shields LE. Baseline assessment of a hospital-specific early warning trigger system for reducing maternal morbidity. Int J Gynaecol Obstet 2016; 132 (03) 337-341
  • 20 Shields LE, Wiesner S, Klein C, Pelletreau B, Hedriana HL. Use of maternal early warning trigger tool reduces maternal morbidity. Am J Obstet Gynecol 2016; 214 (04) 527.e1-527.e6
  • 21 Arnolds DE, Smith A, Banayan JM, Holt R, Scavone BM. National partnership for maternal safety recommended maternal early warning criteria are associated with maternal morbidity. Anesth Analg 2019; 129 (06) 1621-1626
  • 22 Blumenthal EA, Hooshvar N, McQuade M, McNulty J. A validation study of maternal early warning systems: a retrospective cohort study. Am J Perinatol 2019; 36 (11) 1106-1114
  • 23 Plante LA, Pacheco LD, Louis JM. Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org. SMFM consult series #47: sepsis during pregnancy and the puerperium. Am J Obstet Gynecol 2019; 220 (04) B2-B10
  • 24 Main EK, Abreo A, McNulty J. et al. Measuring severe maternal morbidity: validation of potential measures. Am J Obstet Gynecol 2016; 214 (05) 643.e1-643.e10
  • 25 Maguire PJ, O'Higgins AC, Power KA, Daly N, McKeating A, Turner MJ. Maternal bacteremia and the Irish maternity early warning system. Int J Gynaecol Obstet 2015; 129 (02) 142-145
  • 26 Maguire PJ, Power KA, Daly N, Farren M, McKeating A, Turner MJ. High dependency unit admissions during the first year of a national obstetric early warning system. Int J Gynaecol Obstet 2016; 133 (01) 121-122
  • 27 Centers for Disease C. Severe maternal morbidity in the United States. Accessed 2019 at: https://www.cdc.gov/reproductivehealth/maternalinfanthealth/severematernalmorbidity.html
  • 28 Singh A, Guleria K, Vaid NB, Jain S. Evaluation of maternal early obstetric warning system (MEOWS chart) as a predictor of obstetric morbidity: a prospective observational study. Eur J Obstet Gynecol Reprod Biol 2016; 207: 11-17
  • 29 ACOG Committee Opinion No. ACOG committee opinion no. 767: emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol 2019; 133 (02) e174-e180